Kimia Biosciences Ltd Financial Ratios
KIMIABL · Healthcare · Current price ₹29.27
P/E ratio
14.4x
P/B ratio
7.6x
ROE
53.7%
ROCE
42.0%
Debt / Equity
1.94
Dividend yield
0.0%
Ratio reference
| Ratio | Value | What it means |
|---|---|---|
| P/E | 14.4x | Price paid per ₹1 of annual earnings — lower is cheaper (context-dependent). |
| P/B | 7.6x | Price relative to book value — <1 can signal deep value or trouble. |
| ROE | 53.7% | Return on equity — how much profit the company earns on shareholder capital. |
| ROCE | 42.0% | Return on capital employed — efficiency including debt. >15% is strong. |
| D/E | 1.94 | Leverage — higher means more debt-funded, riskier in downturns. |
Model it yourself — PEG Ratio Calculator
Opens pre-filled with Kimia Biosciences Ltd's latest numbers.
Kimia Biosciences Ltd profitability
Kimia Biosciences Ltd generates a return on equity of 53.7% and a return on capital employed of 42.0%. An ROE consistently above 15% usually points to a quality business with a durable advantage; below 10% suggests weak profitability or a capital-heavy model.
Leverage & valuation
With a debt-to-equity of 1.94 and a P/E of 14.4x, Kimia Biosciences Ltd is carrying meaningful debt. Our overall business-quality score for the company is 4.4 / 10.
Understand the ratios
More on Kimia Biosciences Ltd
DocStoX estimates are generated by a deterministic valuation engine from reported financials — for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.